Evidence against structural and functional identity of microtubule-associated protein 1B and proteoglycan claustrin  by Tögel, Martin et al.
Evidence against structural and functional identity of
microtubule-associated protein 1B and proteoglycan claustrin
Martin Toºgel, Gerhard Wiche, Friedrich Propst*
Institute of Biochemistry and Molecular Cell Biology, Vienna Biocenter, University of Vienna, Dr. Bohr-Gasse 9, A-1030 Vienna, Austria
Received 10 December 1997
Abstract Recently, the concept of microtubule-associated
protein 1B as an intracellular 2460 amino acid protein was
challenged by the suggestion that only the N-terminal 1022
codons are utilized and encode the core protein of the
extracellular proteoglycan claustrin (Burg and Cole (1994)
J. Neurobiol. 25, 1^22). We expressed this N-terminal MAP1B
fragment in tissue culture cells and found that it bound to
microtubules and was not localized in the extracellular matrix. In
addition, epitope mapping demonstrated that MAP1B consisted
of more than 1022 amino acids and that the reported cDNA of
claustrin is incomplete.
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1. Introduction
Microtubule-associated protein 1B (MAP1B) is a 280 to 300
kDa ¢brous protein which is predominantly expressed in the
developing nervous system [1,2]. The protein has originally
been identi¢ed by its capacity to bind to and copurify with
brain microtubules during repeated cycles of temperature de-
pendent microtubule polymerization and depolymerization.
Analysis of cDNA clones coding for human, rat and mouse
MAP1B revealed a highly conserved sequence of about 2460
amino acids in all three species [3^6]. The mature protein
consists of a heavy and a light chain which are generated by
posttranslational proteolytic processing of the 2460 amino
acid protein [7].
In marked contrast to these results, an independent study
on the molecular characterization of claustrin, an extracellular
chicken brain keratan sulfate proteoglycan (KSPG), has led to
the suggestion that MAP1B is highly related if not identical to
claustrin [8]. According to this report claustrin/MAP1B con-
tains a core polypeptide of only 1038 amino acids comprising
the N-terminus of the previously identi¢ed 2460 MAP1B pro-
tein. Claustrin does not bind to microtubules and is instead an
extracellular KSPG [8]. These conclusions contradicted a
wealth of previously published evidence that MAP1B is an
intracellular microtubule-associated protein of 2460 amino
acids [2] and were based mainly on three ¢ndings: (i) Screen-
ing of chicken brain cDNA libraries with antibodies to claus-
trin yielded clones with an open reading frame of 1038 codons
highly homologous to the N-terminal part of previously
cloned MAP1B cDNAs. (ii) Treatment of claustrin/MAP1B
with keratanase reduced the apparent molecular weight to 117
kDa. (iii) A monoclonal antibody (mAb) raised against
MAP1B, mAb MAP5 [9], reacted with puri¢ed claustrin on
immunoblots.
We have constructed a rat claustrin homolog, an N-termi-
nal fragment of rat MAP1B which corresponds in length and
sequence to chicken claustrin. This fragment was expressed in
rat kangaroo PtK2 cells, mouse NIH3T3 ¢broblasts and rat
glioma C6 cells and the intra- and extracellular localization of
this protein and its reactivity with the mAb MAP5 were an-
alyzed. We found no evidence that this rat claustrin homolog
is associated with the extracellular matrix. Instead, the protein
bound to microtubules through its previously identi¢ed micro-
tubule binding domain [3,4]. In addition, we found that the
epitope for the MAP5 antibody is not present in this protein
but instead in a region of full-length MAP1B located further
towards the C-terminus. Our results demonstrate that (i) a
protein fragment of MAP1B proposed to be homologous to
the core protein of the extracellular KSPG claustrin can bind
to microtubules in vivo, (ii) that MAP1B consists of more
than the 1038 amino acids proposed by Burg and Cole [8]
and (iii) that the reported cDNA of claustrin is incomplete.
Thus, our results are in agreement with previous reports iden-
tifying MAP1B as a 2460 amino acid intracellular microtu-
bule-associated protein [2] and provide evidence against the
conclusions drawn by Burg and Cole that MAP1B is a 1038
amino acid extracellular KSPG [8].
2. Materials and methods
2.1. Constructs
The full-length rat MAP1B cDNA (MAP1B:1^2459) was obtained
by joining a cDNA fragment isolated from a C6 cell cDNA library
containing exons 1^3 (isolated using a corresponding mouse probe
generously provided by N. Cowan) at a unique Aat2 restriction site
to the existing MAP1B cDNA [4]. A C-terminal in-frame myc-tag was
attached and the sequence £anking the ATG initiator codon was
modi¢ed to optimize expression using PCR based strategies. The cor-
rect sequence of segments derived by PCR was con¢rmed. MAP1B:1^
508, MAP1B:1^1022 and MAP1B:1046^2459 (all with C-terminal in-
frame myc-tag) were derived from MAP1B:1^2459 using convenient
restriction sites and adaptor oligonucleotides. All constructs were
cloned into the Tet-o¡ expression vector pUHD10-3 [10].
2.2. Antibodies
An anti-myc peptide antiserum was raised against the synthetic
peptide CTLAEQKLISEEDN (PiChem, Graz, Austria), a⁄nity puri-
¢ed as described [11] and used at a concentration of 1W g/ml for
immuno£uorescence microscopy and 5 Wg/ml on immunoblots. An
anti-myc mAb (clone 9E10 hybridoma supernatant), a guinea pig
anti-myc antiserum (generously provided by Yuh Nung Jan), an K-
tubulin mAb (Sigma, clone B-5-1-2), an a⁄nity puri¢ed polyclonal
rabbit anti-¢bronectin antibody (Sigma), and the anti-MAP1B mAb
MAP5 (clone AA6, Boehringer Mannheim) were used at dilutions of
1:2, 1:2000, 1:2000, 1:200, and 1:500, respectively. Secondary anti-
bodies: FITC-conjugated anti-rabbit IgG antibody pre-adsorbed
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against mouse IgG, Texas-red-conjugated anti-mouse IgG antibody
pre-adsorbed against rabbit IgG, Texas-red-conjugated donkey anti-
guinea pig antibody (all Jackson, West Baltimore Pike, USA, dilu-
tions 1:50); alkaline phosphatase-conjugated goat anti-rabbit or goat
anti-mouse IgG antibodies (Promega, dilutions 1:7500).
2.3. Immuno£uorescence microscopy and immunoblotting analysis
NIH3T3, C6 and PtK2 cells were grown in high glucose DMEM
supplemented with 10% fetal calf serum in an atmosphere containing
7.5% CO2, seeded onto coverslips or 35 mm diameter plates, trans-
fected with lipofectamin (GIBCO BRL) according to the manufactur-
er’s protocol and harvested after 24 h (C6 and NIH3T3) or 48 h
(PtK2). For immuno£uorescence PtK2 cells were washed in PBS,
¢xed in methanol (320‡C, 10 min), equilibrated in PBS, blocked
with 3% BSA, incubated with the primary antibodies in 1% BSA
for 1 h, washed extensively in PBS, incubated for 1 h with the second-
ary antibody and again washed with PBS. C6 cells were ¢xed using 4%
paraformaldehyde (37‡C), washed with PBS and blocked with 3%
BSA. To stain for extracellular recombinant MAP1B proteins, cells
were then incubated with the guinea pig anti-myc antiserum, washed
extensively in PBS and incubated for 1 h with secondary antibody.
Following further washing in PBS the cells were solubilized with 0.1%
Triton X-100, blocked in 3% BSA and stained for intracellular
MAP1B proteins using the mouse anti-myc mAb. Control cells were
stained for ¢bronectin following the protocol employed for extracel-
lular MAP1B. Specimens were analyzed by confocal microscopy
(MRC600, BioRad). For immunoblot analysis [12], cells were washed
with PBS, lysed in a bu¡er A, containing 8 M urea, 4% SDS, 0.125 M
Tris-HCl pH 6.8, 12 mM EDTA, 0.3% DTT, 10 WM benzamidine,
1 mM PMSF, 2 WM pepstatin, 2 WM aprotinin, 2 WM leupeptin and
bromphenol blue, sonicated, incubated at 65‡C for 10 min and sub-
jected to SDS/PAGE. The samples for Fig. 4, panel a were precipi-
tated with methanol/chloroform [13] and resuspended again in bu¡er
A before fractionation by SDS/PAGE.
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Fig. 1. Schematic representation of MAP1B, claustrin and rat MAP1B constructs. Full-length MAP1B is depicted with the N-terminal microtu-
bule binding domain (¢lled box) and the imperfect 15-mer repeats (hatched box) [3,4]. Claustrin (depicted as an open box) is aligned to the
MAP1B sequence. The numbers denote the percent sequence identity of the respective claustrin segments to the rat MAP1B sequence depicted
above. Solid lines indicate the proteins encoded by the rat MAP1B cDNA constructs used. The numbers in the names of these constructs indi-
cate the ¢rst and last amino acids according to the numbering of full-length rat MAP1B [4,6]. All MAP1B proteins used in this study carried a
C-terminal c-myc epitope tag.
Fig. 2. Transient expression of MAP1B proteins in PtK2 cells. PtK2 cells were transfected with MAP1B:1^508 (A and B) or MAP1B:1^1022
(C and D) and analyzed by double immuno£uorescence microscopy using the polyclonal rabbit anti-myc antibody (A and C) and the K-tubulin
mAb (B and D). Note the di¡use intracellular localization of MAP1B:1^508 (A) and the di¡use as well as ¢brillar localization of MAP1B:1^
1022 (C). Fibrillar staining colocalized with microtubules (arrows). The bar indicates 10 Wm.
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3. Results
The reported amino acid sequence of chicken claustrin [8]
comprises 1038 amino acids which correspond to amino acids
1^1022 of mouse, rat and human MAP1B [3^6]. In this re-
gion, claustrin and rat MAP1B share an overall sequence
identity of 77%. The N-terminal 550 amino acids of the pro-
teins are 91% identical, the remaining 488 amino acids of
claustrin are 60% identical to the corresponding region in
MAP1B (Fig. 1). This pattern of sequence homology, a highly
related N-terminus of 550 amino acids with a drop in homol-
ogy in the subsequent 500 amino acids, is reminiscent of the
pattern of sequence conservation of mouse, rat, and human
MAP1B. Taken together, these observations suggest that the
cDNA reported for claustrin [8] might indeed be an N-termi-
nal cDNA fragment of chicken MAP1B.
To directly test the relationship between MAP1B and claus-
trin we investigated subcellular localization, microtubule bind-
ing, and reactivity with monoclonal antibodies of a rat
MAP1B fragment corresponding to claustrin. We generated
a construct encoding rat MAP1B amino acids 1^1022 fused to
a short c-myc peptide epitope tag for convenient immunolog-
ical detection (MAP1B:1^1022; Fig. 1). For control purposes,
similar myc-tagged cDNA fragments coding for amino acids
1^508 (MAP1B:1^508), 1^2459 (MAP1B:1^2459), and 1046^
2459 (MAP1B:1046^2459, Fig. 1) were obtained. Expression
of all constructs was put under the control of the tetracyclin
responsive CMV promoter (Tet-o¡ expression system; [10])
which proved to be a strong promoter in PtK2 and C6 cells
in the presence of the appropriate transactivator. All experi-
ments were carried out in the absence of tetracyclin to ensure
high level expression during the ¢rst 24^48 h after transfec-
tion.
The MAP1B:1^1022 protein was detected in transfected
PtK2 cells by immunocytochemistry using a polyclonal rabbit
antibody to the myc-tag (Fig. 2C). The protein appeared to be
expressed in the cytoplasm, both in di¡use and ¢brillar man-
ner. Double labelling with an anti-tubulin mAb revealed co-
localization of ¢brillar MAP1B:1^1022 and microtubules
(Fig. 2C and D). In contrast, MAP1B:1^508, an N-terminal
fragment of rat MAP1B lacking the previously identi¢ed mi-
crotubule binding domain [3,4] did not colocalize with micro-
tubules (Fig. 2A and B). Thus, binding of MAP1B:1^1022 to
microtubules is dependent on its microtubule binding domain.
These results demonstrated that MAP1B:1^1022 is an intra-
cellular protein which binds to microtubules in vivo.
We next expressed MAP1B:1^1022 in C6 glioma cells. We
chose this cell line, because unlike PtK2 cells, C6 cells express
high levels of endogenous rat MAP1B [4]. If MAP1B/claustrin
was indeed an extracellular protein as postulated [8], a puta-
tive transport mechanism necessary to transport MAP1B:1^
1022 into the extracellular domain should be operating in C6
cells. However, immunocytochemistry of C6 cells transfected
with MAP1B:1^1022 showed a staining pattern typical for
intracellular proteins and did not reveal extracellular localiza-
tion of MAP1B:1^1022 (Fig. 3A and B), despite the fact that
C6 cells were competent in exporting ¢bronectin and forming
an extracellular matrix as revealed by staining with the anti-
¢bronectin antibody (Fig. 3C).
Finally, we tested the reactivity of MAP1B:1^1022, the rat
homolog of claustrin, with the mAb MAP5, because the re-
activity of this antibody with claustrin has been pivotal for the
conclusion that MAP1B and claustrin might be identical [8].
Constructs encoding MAP1B:1^1022, full-length rat MAP1B
(MAP1B:1^2459) or MAP1B:1046^2459 were transfected into
NIH3T3 cells and whole cell lysates of transfected cells were
analyzed by immunoblotting using the mAb MAP5 (Fig. 4).
We found that full-length MAP1B was expressed and detect-
able with the MAP5 antibody. The ectopically expressed pro-
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Fig. 3. Transient expression of MAP1B:1^1022 in rat glioma C6
cells. C6 cells were transfected with the construct encoding
MAP1B:1^1022. Intracellular expression of the protein was detected
with the mouse anti-myc mAb (A, arrows indicating three trans-
fected cells). The same cells had before been stained for extracellular
expression of MAP1B:1^1022 (see Section 2) using the guinea pig
anti-myc antiserum (B, arrows indicating the position of the three
transfected cells). Note the di¡use intracellular localization of
MAP1B:1^1022 in transfected cells (A). Due to paraformaldehyde
¢xation, the localization of microtubules cannot be detected in this
experiment. There is no evidence for the presence of MAP1B:1^
1022 in the extracellular matrix. This result is not due to a failure
of the guinea pig anti-myc antiserum to detect extracellular
MAP1B:1^1022 since identical results were obtained using the
mouse anti-myc mAb for extracellular and the guinea pig anti-myc
antiserum (not shown). Control cells were stained for the presence
of ¢bronectin in the extracellular matrix (C). The bar indicates
10 Wm.
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tein comigrated on SDS-polyacrylamide gels with endogenous
PC12 cell MAP1B. This result established that NIH3T3 cells
could be used to express MAP1B and that the expressed pro-
tein was indistinguishable from endogenous MAP1B found in
PC12 cells. MAP1B:1046^2459, the MAP1B fragment com-
prising the region of MAP1B not corresponding to claustrin
was also detected by mAb MAP5. In contrast, MAP1B:1^
1022 was not detected. This was not due to lack of expression
since the protein was detected by the polyclonal antibody to
its myc-tag. The apparent size of MAP1B:1^1022 was larger
than the expected 115 kDa indicating posttranslational mod-
i¢cation. However, it was clearly not as large as endogenous
MAP1B (PC12 cells, Fig. 4).
These results re¢ned the previously reported localization of
the MAP5 epitope on MAP1B. In combination with pub-
lished observations [4] the position of the MAP5 epitope
can now be narrowed down to a region between amino acids
1046 (the beginning of MAP1B:1046^2459) and 1107 (the end
of clone 14I; [4]). This region of MAP1B is C-terminal to the
region corresponding to claustrin and therefore has no coun-
terpart in claustrin.
The previous localization of the MAP5 epitope was carried
out using de¢ned MAP1B protein fragments expressed in E.
coli [4], ruling out the possibility that MAP5 recognizes a
putative keratan sulfate moiety of MAP1B. To exclude that
due to sequence variation the epitope of the mAb MAP5
localized in rat MAP1B between amino acids 1046^1107 is
present in chicken claustrin (amino acids 1^1038) we searched
for sequences of at least 5 consecutive amino acids identical in
claustrin 1^1038 and MAP1B 1046^1107. No such identical 5-
amino acid stretches were found. Thus, the MAP5 epitope did
not appear to be present in claustrin and conclusions concern-
ing the identity of claustrin and MAP1B based on results
obtained with this antibody [8] appear to be unfounded.
4. Discussion
In a recent report, Burg and Cole (1994) describe the mo-
lecular cloning of the cDNA for claustrin, an extracellular
KSPG expressed in chicken brain. The cDNA was isolated
using antibodies raised against puri¢ed claustrin. Sequencing
revealed an open reading frame of 1038 amino acids with a
sequence identity of 77% to the ¢rst 1022 amino acids of rat
MAP1B. This ¢nding together with the observed crossreactiv-
ity of puri¢ed claustrin with the anti-MAP1B mAb MAP5 as
well as the apparent sensitivity of claustrin/MAP1B to treat-
ment with keratanase prompted the authors to suggest that
claustrin might be identical to MAP1B and that MAP1B was
an extracellular KSPG rather than an intracellular microtu-
bule-associated protein [8]. These suggestions were made de-
spite the previous identi¢cation of MAP1B cDNAs with con-
tiguous open reading frames of 2464, 2459 and 2468 amino
acids in mouse, rat and human [3^6], only the ¢rst 1022 of
which are homologous to claustrin.
In the present study we thought to test the hypothesis that
claustrin is identical to MAP1B by analyzing subcellular local-
ization and antibody reactivity of appropriately designed re-
combinant MAP1B fragments. Given the high degree of se-
quence conservation between chicken claustrin and the N-
terminal 1022 amino acids of mammalian MAP1B, we as-
sumed in accordance with Burg and Cole [8] that results
found for chicken claustrin/MAP1B should be reproducible
in mammalian systems. We have therefore transiently ex-
pressed the N-terminal rat MAP1B fragment of 1022 amino
acids, corresponding in length and sequence to claustrin, in
PtK2, NIH3T3 and C6 cells and analyzed its subcellular local-
ization and its reactivity with the anti-MAP1B mAb MAP5.
Neither with PtK2 cells nor with C6 glioma cells did we ¢nd
evidence for extracellular localization of this protein (Figs. 2
and 3). In contrast, we were able to show that the protein
binds to microtubules in vivo and that microtubule binding is
dependent on the presence of the microtubule binding domain
previously assigned to the region between amino acids 525 to
805 [3,4].
A ¢nding pivotal for the suggestion that claustrin is identi-
cal to MAP1B was the observation that puri¢ed claustrin
reacts with the anti-MAP1B mAb MAP5 [8]. The epitope of
this antibody has previously been mapped to a region between
amino acids 693 to 1107 [4]. This epitope mapping was carried
out with MAP1B fragments expressed in E. coli, indicating
that MAP5 recognized a peptide epitope and not, as suggested
by Burg and Cole, a putative keratan sulfate moiety on
MAP1B/claustrin [8]. By expressing recombinant MAP1B
constructs in NIH3T3 cells and analysing the reactivity of
the expressed proteins by immunoblots we were able to limit
the epitope-containing region of MAP1B to amino acids 1046
to 1107 (Fig. 4). This region is C-terminal to the part of
MAP1B (amino acids 1^1022) which was reported to be ho-
mologous to claustrin [8]. Our results demonstrate that
MAP1B must comprise a larger portion of the previously
identi¢ed 2459 amino acid open reading frame than amino
acids 1^1022. Furthermore, we show that MAP1B:1046^
2459 is signi¢cantly smaller than MAP1B:1^2459 or endoge-
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Fig. 4. Immunoblot analysis of NIH3T3 cells expressing MAP1B
constructs. Whole cell lysates of NIH3T3 cells transiently trans-
fected with the indicated constructs were analyzed by immunoblot-
ting using the anti-MAP1B mAb MAP5 or the polyclonal rabbit
anti-myc antibody as indicated. A whole cell lysate of rat pheochro-
mocytoma PC12 cells which express endogenous MAP1B was used
as positive control. The band detected with the polyclonal rabbit
anti-myc antibody was speci¢c for cells transfected with MAP1B:1^
1022 and was not seen in control cells (not shown). Panels a and b
are immunoblots obtained from separate gels.
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nous MAP1B whereas all three proteins react with MAP5,
indicating that a portion of the MAP1B open reading frame
containing amino acids 1^1022 contiguous with additional
amino acids is translated to yield high molecular mass
MAP1B. This conclusion is supported by the ¢nding that at
least two additional mAbs to MAP1B react with epitopes
located further to the C-terminus of the MAP1B open reading
frame between amino acids 1639 to 2080 [4]. Taken together,
these results provide strong evidence for the prevailing con-
cept of MAP1B being translated as a 2459 amino acid protein
and contradict the suggestion that MAP1B contains a core
protein of only 1038 amino acids whereas the rest of the
protein mass is made up by posttranslational modi¢cations
[8]. At the same time our results show that the reported claus-
trin cDNA has insu⁄cient coding capacity to code for a pro-
tein reactive with the anti-MAP1B mAb MAP5. Thus, if
claustrin was related to MAP1B as suggested by Burg and
Cole based on the reactivity with the MAP5 antibody [8] it
must comprise a larger region of homology with MAP1B than
the reported 1022 amino acids.
Our results do not exclude the possibility that MAP1B and
claustrin are immunologically related. In fact, extracellular
proteins immunologically related to MAP1 and/or MAP2
have been reported elsewhere [14]. However, the suggested
strict identity [8] of the two proteins appears to be unlikely
in the light of the results presented here which argue against
the rede¢nition of MAP1B as an extracellular KSPG.
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